Vimarsana
Biggest News Aggregation in the World

Page 2 - Delasmogen Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Delasmogen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Delasmogen Ltd Today - Breaking & Trending Today

UW study finds hope against COVID in unlikely source: shark antibodies - Vimarsana News

UW study finds hope against COVID in unlikely source: shark antibodies

Nurse sharks at The University of Wisconsin-Madison may provide antibodies for COVID-19, according to new study in the journal Nature Communications.

UW study finds hope against COVID in unlikely source: shark antibodies - Vimarsana News

UW study finds hope against COVID in unlikely source: shark antibodies

Nurse sharks at The University of Wisconsin-Madison may provide antibodies for COVID-19, according to new study in the journal Nature Communications.

Shark antibody-like proteins neutralize COVID-19 virus, help prepare for future coronaviruses - Vimarsana News

Shark antibody-like proteins neutralize COVID-19 virus, help prepare for future coronaviruses

Small, unique antibody-like proteins known as VNARs — derived from the immune systems of sharks — can prevent the virus that causes COVID-19, its variants,

UW study finds hope against COVID in unlikely source: shark antibodies - Vimarsana News

UW study finds hope against COVID in unlikely source: shark antibodies

Nurse sharks gliding around a tank at the University of Wisconsin-Madison may hold the secret to an unusual treatment for COVID-19, according to a new study in the journal Nature Communications.

Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners - Vimarsana News

Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners

Share this article Share this article ABERDEEN, Scotland, Jan. 25, 2021 /PRNewswire/ -- Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, today announces a significant breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping COVID-19 infections. This new approach has been achieved through a close partnership with the University of Minnesota, USA and represents an excellent example of the new spirit of research collaboration that has accelerated the global fight-back against COVID-1...